Defect of Platelet Aggregation and Adhesion Induced by Autoantibodies Against Platelet Glycoprotein IIIa

Summary

A young patient developed chronic idiopathic thrombocytopenic purpura. Prednisone therapy normalized platelet number, but bleeding symptoms did not disappear. Platelet function was severely impaired, since platelet aggregation, ATP release and adhesion to collagen and subendothelial matrix were significantly reduced. Plasma and purified immunoglobulins of the patient reproduced the functional defects in normal platelets. Immunoblotting revealed that patient’s plasma contained an antibody reacting with a component of platelets with the same electrophoretic mobility of glycoproteins IIIa of normal platelets. Moreover, patient’s plasma inhibited the binding of an anti-GPIIb/IIIa monoclonal antibody to platelet surface. Additional immunosuppressive therapy with prednisone and azathioprine normalized platelet function and induced the disappearance of bleeding symptoms.

• References

• 1 Kotite NJ, Staros JV, Cunningham LW. Interaction of specific platelet membrane proteins with collagen: evidence from chemical cross-linking. Biochemistry 1984; 23: 3095-104
• 2 Shadle PJ, Ginsberg MN, Plow EF, Barondes SH. Platelet-collagen adhesion: inhibition by a monoclonal antibody that binds glycoprotein IIb. J Cell Biol 1984; 99: 2056-2060
• 3 Tsunehisa S, Tsuji T, Tohyama H, Osawa T. Interaction of human platelet membrane glycoproteins with collagen and lectins. Biochim Biophys Acta 1984; 797: 10-19
• 4 Coller BS, Beer JH, Scudder LE, Steinberg MH. Collagen-platelet interactions: evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins. Blood 1989; 74: 182-192
• 5 Lawrence JB, Gralnick HR. Monoclonal antibodies to the glycoproteins IIb–IIIa epitopes involved in adhesive protein binding: effect on platelet spreading and ultrastructure on human arterial subendothelium. J Lab Clin Med 1987; 109: 495-503
• 6 Sakariassen KS, Nievelstein PFEM, Coller BS, Sixma JJ. The role of platelet membrane glycoproteins Ib and IIb–IIIa in platelet adherence to human artery subendothelium. Br J Haematol 1986; 63: 681-691
• 7 Weiss HJ, Turitto VT, Baumgartner HR. Platelet adhesion and thrombus formation on subendothelium in platelet deficient in glycoproteins IIb–IIIa, Ib and storage granules. Blood 1986; 67: 322-330
• 8 Weiss HJ, Turitto VT, Baumgartner HR. Further evidence that glycoprotein IIb–IIIa mediates platelet spreading on subendothelium. Thromb Haemostas 1991; 65: 202-205
• 9 Packham MA, Kinlough-Rathbone RL, Mustard JF. Thromboxane A₂ causes feedback amplification involving extensive thromboxane A₂ formation on close contact of human platelets in media with a low concentration of ionized calcium. Blood 1987; 70: 647-651
• 10 Nurden A. Platelet membrane glycoproteins and their clinical aspect. In: Thrombosis and Haemostasis 1987. Leuven University Press; Leuven:
• 11 Balduini CL, Sinigaglia F, Damiani G, Bertolino G, Bisio A, Zocchi E. Effect of a monoclonal antibody against GPs IIb–IIIa on platelet aggregation and ATP secretion. Exp Hematol 1986; 14: 338-342
• 12 Zabinski MP, Raymond SL, Catalfamo JL. Platelet adhesion to noncovalently immobilized collagen. J Lab Clin Med 1984; 103: 236-245
• 13 Balduini CL, Sinigaglia F, Salvini P, Balduini C. The role of plasma fibronectin in platelet adhesion to collagen. Haemostasis 1984; 14: 158-163
• 14 Houdijk WPM, Sakariassen KS, Nievelstein PFEM, Sixma JJ. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. J Clin Invest 1985; 75: 531-540
• 15 Piovella F, Ricetti MM, Almasio P, Castagnola C, Pesenti Compagnoni M, Gallotti P, Feoli FR, Ascari E. Characterization and synthesis of some factor VIII related properties in cultured human endothelial cells. Haematologica 1979; 64: 614-625
• 16 De Groot PG, Reinders JH, Sixma JJ. Pertubation of human endothelial cells by thrombin or PMA changes the reactivity of their extracellular matrix toward platelets. J Cell Biol 1987; 104: 697-704
• 17 Sakariassen KS, Aarts PAMM, De Groot PG, Houdijk WPM, Sixma JJ. A perfusion chamber developed to investigate platelet interactions in flowing blood with human vessel wall cells, their extracellular matrix and purified components. J Lab Clin Med 1983; 102: 522-535
• 18 Brass LF, Faile D, Bensusan B. Direct measurement of the platelet: collagen interaction by affinity chromatography on collagen/Sepharose. J Lab Clin Med 1976; 87: 527-534
• 19 Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
• 20 Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1970; 193: 265-275
• 21 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4354
• 22 Fitzgerald LA, Leung B, Phillips DR. A method for purifying the platelet membrane glycoprotein IIb–IIIa complex. Anal Biochem 1985; 151: 169-177
• 23 DiMinno G, Coraggio F, Carbone AM, Capitanio AM, Manzo C, Spina M, Scarpato P, Dattoli GMR, Mattioli PLM, Mancini M. A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding. J Clin Invest 1986; 77: 157-164
• 24 Kubota T, Tanoue K, Murohashi I, Nara N, Yamamoto N, Yamazaki H, Aoki N. Autoantibody against platelet glycoprotein IIb–IIIa in a patient with non-Hodgkin’s lymphoma. Thromb Res 1989; 53: 379-386
• 25 Balduini CL, Grignani G, Sinigaglia F, Bisio A, Pacchiarini L, Rota Scalabrini D, Balduini C, Mauri C, Ascari E. Severe platelet dysfunction in a patient with autoantibodies against membrane glycoproteins IIb–IIIa. Haemostasis 1987; 7: 98-104
• 26 Meyer M, Kirchmaier CM, Schirmer A, Spangenberg P, Strohl Ch, Breddin K. Acquired disorder of platelet function associated with autoantibodies against GPIIb–IIIa complex. Thromb Haemostas 1991; 65: 491-496
• 27 Niessner H, Clemetson KJ, Panzer S, Mueller-Eckardt C, Santoso S, Betteiheim P. Acquired thrombasthenia due to GPIIb–IIIa specific autoantibodies. Blood 1986; 68: 571-576
• 28 Reid DM, Jones CE, Vostal JG, Shulman NR. Western blot identification of platelet proteins that bind normal serum immunoglobulins. Characteristics of a 95-kDa reactive protein. Blood 1990; 75: 2194-203
• 29 Coller BS, Peerschke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest 1983; 72: 325-338
• 30 DiMinno G, Thiagarajan P, Perussia B, Martinez J, Shapiro S, Trinchieri G, Murfy S. Exposure of platelet fibrinogen-binding site by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb–IIIa complex. Blood 1983; 61: 140-148
• 31 Coller BS. Report of the working party on hybridoma-derived monoclonal antibodies to platelets. Thromb Haemostas 1984; 51: 169-173
• 32 Heirich D, Scharf T, Santoso S, Clemetson KJ, Mueller-Eckhardt C. Monoclonal antibodies against human platelet membrane glycoproteins IIb–IIIa. II. Different effects on platelet function. Thromb Res 1985; 38: 547-549
• 33 Balduini CL, Bertolino G, Noris P, Sinigaglia F, Bisio A, Torti M. Interrelation of platelet aggregation, release reaction and thromboxane A₂ production. Biochem Biophys Res Commun 1988; 156: 823-829